ABRAHAM N. OLER - 14 Jan 2022 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)

Role
SVP CORP DEV & GEN COUNSEL
Signature
/s/ Mark Guerin as attorney-in-fact
Issuer symbol
TRAW
Transactions as of
14 Jan 2022
Net transactions value
+$3,300
Form type
4
Filing time
18 Jan 2022, 08:12:56 UTC
Previous filing
10 Jan 2022
Next filing
24 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONTX Common Stock Purchase $3,300 +1,500 +7.5% $2.20 21,514 14 Jan 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee.